Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAGINE: Quinapril Post-CABG
NCT00269243Phase 4Completed
- Sponsor
- Montréal Heart Institute
- Start
- Nov 1999
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Quinapril with Placebo (2 arms). Primary endpoint: Time to first occurrence of cardiovascular death, resuscitated cardiac arrest, nonfatal myocardial infarction, coronary revascularization, unstable angina requiring hospitalization, documented… at 43 months. Started Nov 1999; status: completed.
02
Drugs
quinapril
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00269243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269243.